title: New diagnostic tests for pneumonia: what is their role in clinical practice?
abstract: The utility of diagnostic studies to determine the etiologic agents of community-acquired pneumonia has been controversial in part because of the lack of rapid, accurate, easily performed, and cost-effective methods. Advancements in molecular testing methods and biological markers are becoming available with marked expansion of diagnostic capability for infectious diseases. Subsequent studies and clinical experience will clarify their real clinical value.
authors.affiliation: Infectious Disease Section, Internal Medicine Department, Northeastern Ohio Universities College of Medicine and Pharmacy, Rootstown, OH 44272, USA. filet@summahealth.org
authors.forename: Thomas M
authors.initials: TM
authors.lastname: File
mesh_terms: D000942:Antigens, Bacterial / Q000652:urine; D002116:Calcitonin / Q000097:blood; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000378:metabolism / Q000382:microbiology* / Q000821:virology; D006801:Humans; D021141:Nucleic Acid Amplification Techniques; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000378:metabolism; D011024:Pneumonia, Viral / Q000175:diagnosis* / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011498:Protein Precursors / Q000097:blood
chemical_list: D000942:Antigens, Bacterial; D011498:Protein Precursors; D002116:Calcitonin